CTCA is proud to share the expertise of our physicians through a series of free CME education, both virtual and live. Driven by the goal of improving patient care, our CME program is dedicated to providing a robust, well-rounded portfolio of CME activities that contribute to the greater good of our clinical communities.
This program highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as: screening high-risk patients, cancer pain management, immunotherapy treatment & adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment and drug-drug interactions.
Upon completion of this activity, participants will be able to:
Faculty:
Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.
Upon completion of this activity, participants will be able to:
Faculty:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.
Upon completion of this activity, participants will be able to:
Faculty:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sino-nasal undifferentiated carcinoma of the head & neck, and adenocarcinoma of the lung.
Upon completion of this activity, participants will be able to:
Faculty:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: colon adenocarcinoma, endometrial adenocarcinoma and breast invasive ductal carcinoma (IDC).
Upon completion of this activity, participants will be able to:
Faculty: